The maximum growth of Cardiac Assist Devices is being generated from the Ventricular Assist Devices (VAD) market. United States is the largest market for the Ventricular Assist Devices. The market is expected to be driven by increasing rates of cardiovascular diseases and the aging population. The shortage of donor hearts for transplantation is also leading to an increase in adoption of ventricular assist devices in patients with end-stage heart failure. Technological advancements that make the devices more efficient and minimally invasive are expected to further drive the demand for cardiac assist devices in the future. The market is segmented according to types of devices and geography (North America, Europe, Asia Pacific and Rest of the World).
Advancements in cardiac disease prevention technology, Increase in aging population and increasing prevalence in cardiovascular disease are some of the factors augmenting the growth of the ventricular assist devices market.
Expensive Instruments and maintenance and stringent regulatory policies are hindering the growth of the market.
This Report Offers:
1)Market Definition for the specified topic along with identification of key drivers and restraints for the market.
2)Market analysis for the Global Ventricular Assist Devices Market, with region specific assessments and competition analysis on a global and regional scale.
3)Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4)Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
5)Identification and analysis of the Macro and Micro factors that affect the Global Ventricular Assist Devices Market on both global and regional scale.
6)A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
1.1 Report Description
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Advancements in cardiac disease prevention technology
3.2.2 Increase in aging population
3.2.3 Increasing prevalence in cardiovascular disease
3.3 Market Restraints
3.3.1 Expensive Instruments and maintenance
3.3.2 Stringent regulatory policies
3.4 Market Opportunitites
3.5 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Global Ventricular Assist Devices Market
5.1.1 By Types of Devices
220.127.116.11 Left ventricular assist devices (LVAD)
18.104.22.168 Right ventricular assist devices (RVAD)
22.214.171.124 Biventricular assist devices (BIVAD)
5.1.2 By Geography
126.96.36.199 North America
188.8.131.52 Asia Pacific
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.3 CALON CARDIO
7.5 CARDIOBRIDGE GMBH
7.6 CARDIOKINETIX, INC
7.8 CORASSIST CARDIOVASCULAR LTD
7.11 SUNSHINE HEART
7.12 SYNCARDIA SYSTEMS
7.13 TERUMO CORPORATION